Exam (elaborations)
Exam 1: NURS617/ NURS 617 (Latest 2024/ 2025 Update) Pharmacotherapeutics Review| Qs & As| Grade A| 100% Correct (Verified Answers)- Southeastern Louisiana
Exam 1: NURS617/ NURS 617 (Latest 2024/ 2025 Update) Pharmacotherapeutics Review| Qs & As| Grade A| 100% Correct (Verified Answers)- Southeastern Louisiana
Q: Use of pharmacogenomics can: CHOOSE ONE ANSWER
a. Identify patients with genetic factors responsible for variable responses to certai...
[Show more]
Preview 4 out of 73 pages
Uploaded on
December 5, 2024
Number of pages
73
Written in
2024/2025
Type
Exam (elaborations)
Contains
Questions & answers
nurs617 nurs 617 pharm
nurs617 nurs 617 pharmacotherapeutics exam
nurs617 nurs 617 pharmacotherapeutics exam 1
nurs617 nurs 617 pharmacotherapeutics exam 2
nurs617 nurs 617 pharmacotherapeutics exam 3
$11.49
Also available in package deal from $13.99
100% satisfaction guarantee
Immediately available after payment
Both online and in PDF
No strings attached
Also available in package deal (3)
1. Exam (elaborations) - Exam 1: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics | qs & as| ...
2. Exam (elaborations) - Exam 1: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
Show more
1. Exam (elaborations) - Exam 1: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics | qs & as| ...
2. Exam (elaborations) - exam 3: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics guide| qs ...
3. Exam (elaborations) - Exam 1: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
4. Exam (elaborations) - Exam 2: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics guide | qs ...
5. Exam (elaborations) - Exam 2: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
6. Exam (elaborations) - Exam 3: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
7. Exam (elaborations) - Final exam: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review|...
8. Exam (elaborations) - Final exam: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics guide| ...
Show more
1. Exam (elaborations) - Exam 1: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics | qs & as| ...
2. Exam (elaborations) - Exam 1: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
3. Exam (elaborations) - Exam 2: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics guide | qs ...
4. Exam (elaborations) - Exam 2: nurs617/ nurs 617 (latest 2024/ 2025 update) pharmacotherapeutics review| qs ...
Show more
Examl1:lNURS617/lNURSl617l(Latestl
Update)lPharmacotherapeuticslReview|lQsl
&lAs|lGradelA|l100%lCorrectl(Verifiedl
Answers)-lSoutheasternlLouisiana
Q:lUseloflpharmacogenomicslcan:lCHOOSElONElANSWERl
a.lIdentifylpatientslwithlgeneticlfactorslresponsiblelforlvariablelresponsesltolcertainldrugsl
b.lPotentiallylmakelpharmacotherapylanlobsoletelpracticel
c.lAlterlanlindividual'slsetloflCYP450lenzymesl
d.lEliminateladverseleffectslassociatedlwithlalllformsloflpharmacotherapy
Answer:
a.lIdentifylpatientslwithlgeneticlfactorslresponsiblelforlvariablelresponsesltolcertainldrugs
Q:lSomelmedicationslworklbylinteractingldirectlylwithlalspecificlenzymeltoldecreaselitslactio
n.lWhichlscenariolislanlexampleloflaldrugl-lenzymelinteraction?lCHOOSElONElANSWER
a.lStoollsoftenerslalteringlthelsurfaceloflhardlstoollallowinglwaterlfromlthelcolonicllumenltolent
erlthelstool,lmakinglitlsofter.l
b.lActivatedlcharcoallbindingltolorallylingestedldrugslandltoxins,lpreventingltheirlabsorptionl
c.lDigoxinlbindingltolNal/lKlATPaselinhibitinglthelmovementloflsodiumlionslfromlwithinlthelc
ardiaclmusclelcellslandlenhancinglthelentryloflcalciumlionslintolthelcell
d.lAntacidslblockinglthelsecretionloflacidlbylgastriclcellsltolreducelaciditylinlthelstomach
Answer:
c.lDigoxinlbindingltolNal/lKlATPaselinhibitinglthelmovementloflsodiumlionslfromlwithinlthelc
ardiaclmusclelcellslandlenhancinglthelentryloflcalciumlionslintolthelcell
Q:lWhichldruglmoleculeslarelreadilylableltolenterlandlcrosslthellipidlcontentloflthelcelllmemb
rane?lCHOOSElONElANSWERl
a.lFatlsolublel
b.lHydrophiliclsubstancesl
,c.lIonizedl
d.lPolarized
Answer:
a.lFatlsoluble
Q:lWhichloflthelfollowingldrugslcanlbelusedltolformlanlirreversiblelchemicallbondlbetweenlt
hemselveslandlanotherlmolecularlsubstance?lCHOOSElONElANSWERl
a.lCholestyraminel(Questran)l
b.lMannitoll
c.lSucralfatel
d.lTalcumlpowder
Answer:
a.lCholestyraminel(Questran)
Q:lBiotransformationloflaldruglresultslin?lCHOOSElONElANSWERl
a.lEasierldistributionl
b.lFasterlurinarylexcretionl
c.lHigherlproteinlbindingl
d.lSlowerlurinarylexcretion
Answer:
b.lFasterlurinarylexcretion
Q:lWhichlstatementlisltruelconcerninglpharmacokineticlvariationslinlalpediatriclpatient?lCHO
OSElONElANSWER
a.lDrugsladministeredltopicallyltolthelskinlinlneonates,linfants,landlsmalllchildrenlwilllbelabsor
bedlfasterlthanlthelsameldruglappliedltolthelskinloflanladultl
b.lNeonateslhavelallargerlpercentagelofltheirlbodylweightlaslfatlallowinglalwiderldistributionlof
lfatl-lsolubleldrugs
c.lBecauseldruglmetaboliclrateslarelproportionalltolbasallbodyltemperatures,ldruglmetabolismlin
lneonateslandlinfantslislgenerallylslowerlthanlanladult.l
,d.lGlomerularlfiltrationlandlrenalltubularlexcretionldoeslnotlchangelinlthellifespanloflallpatient.
Answer:
a.lDrugsladministeredltopicallyltolthelskinlinlneonates,linfants,landlsmalllchildrenlwilllbelabsor
bedlfasterlthanlthelsameldruglappliedltolthelskinloflanladult
Q:lWaterlsolubleldrugslhavelgoodlabsorptionlthroughlalllthelfollowinglrouteslEXCEPT:lCHO
OSElONElANSWERl
a.lEnterall
b.lIntravenousl
c.lTransdermall
d.lTransrectal
Answer:
c.lTransdermal
Q:lUnlesslcontraindicatelorlnotltolerated,lwhichldruglclasslshouldlbelgivenltolalllpatientslwith
lalrecentlorlremotelhistoryloflmyocardiallinfarction?lCHOOSElONElANSWERl
a.lBetalblockersl
b.lDiureticsl
c.lCardiaclglycosidesl
d.lNitrates
Answer:
a.lBetalblockers
Q:lDueltolelectrolyteldepletion,lalpatientltakinglalthiazideldiureticlmaylalsolneedltolreceivelth
elfollowinglsupplementlCHOOSElONElANSWERl
a.lCalciuml
b.lMagnesiuml
c.lPhosphatesl
d.lPotassium
, Answer:
d.lPotassium
Q:lWhichloflthelfollowingldrugslislLEASTlappropriatelforltreatinglalpatientlwithlheartlfailure
landlasthma?l
a.lBenazeprill(Lotensin)l
b.lCarvediloll(Coreg)l
c.lFurosemidel(Lasix)l
d.lMetoprololl(Lopressor,lToprollXL)
Answer:
b.lCarvediloll(Coreg)
Q:lRoutinelmonitoringloflPTlandlINRlislnecessarylwithlwhichloflthelfollowingldrugs?lCHOO
SElONElANSWERl
a.lPrasugrell(Effient)l
b.lRivaroxabanl(Xarelto)l
c.lStreptokinasel(Streptase)l
d.lWarfarinl(Coumadin)
Answer:
d.lWarfarinl(Coumadin)
Q:lWhenltreatinglangina,lincorporatingl'ldruglholidaysl'linlalpatient'sldruglregimenlmaylhelpl
preventltolerancelandlphysicalldependencelwithlwhichldruglclass?lCHOOSElONElANSWER
a.lAngiotensinlReceptorlblockersl
b.lDiureticsl
c.lNitratesl
d.lStatins
Answer:
c.lNitrates